Company Filing History:
2 out of 25 
1 out of 15 
1 out of 64 Years Active: 2023
Title: The Innovative Mind of Hyun Min Ryu
Introduction
Hyun Min Ryu is a notable inventor based in Daejeon, South Korea, recognized for his contributions to the field of biomedicine. With a focus on antibody-drug conjugates (ADCs), he has developed innovative methods and compositions that hold significant promise in the treatment of various diseases, particularly cancer. Ryu's work has led to the filing of two patents, showcasing his relentless pursuit of innovation in therapeutic solutions.
Latest Patents
Hyun Min Ryu's latest patents demonstrate his expertise in the domain of targeted therapy. His first patent, related to compositions and methods for anti-CD19 antibody drug conjugates, describes the innovative approach of linking active agents to an anti-CD19 antibody through a specialized linker. This invention lays the groundwork for the creation of monoclonal antibodies and antigen-binding fragments that specifically target CD19, offering potential in various therapeutic and diagnostic applications.
His second patent focuses on an ADC targeting ROR1, a protein often over-expressed in certain cancers. This invention details the creation and application of ADCs that bind to ROR1, including their method of preparation and usage in clinical settings. These innovations are poised to enhance treatment options for illnesses associated with ROR1, showcasing Ryu's commitment to addressing unmet medical needs.
Career Highlights
Throughout his career, Hyun Min Ryu has been associated with reputable companies such as Legochem Biosciences, Inc. and Abl Bio Inc. His experiences in these organizations have enriched his expertise and enabled his contributions to cutting-edge research and development in the pharmaceutical field.
Collaborations
In his journey as an inventor, Ryu has collaborated with notable peers, including Ho Young Song and Sung Min Kim. These collaborations demonstrate the importance of teamwork and shared vision in driving forward scientific advancements and innovations.
Conclusion
Hyun Min Ryu stands out as an inventive force in the biotechnology sector. His patents not only reflect his technical proficiency but also highlight his dedication to improving health outcomes through scientific innovation. As research continues to evolve, Ryu remains a key figure in the ongoing development of targeted therapies that could revolutionize cancer treatment and other diseases.